全文获取类型
收费全文 | 1116篇 |
免费 | 78篇 |
国内免费 | 28篇 |
专业分类
儿科学 | 76篇 |
妇产科学 | 16篇 |
基础医学 | 95篇 |
口腔科学 | 49篇 |
临床医学 | 141篇 |
内科学 | 271篇 |
皮肤病学 | 13篇 |
神经病学 | 23篇 |
特种医学 | 257篇 |
外科学 | 91篇 |
综合类 | 21篇 |
预防医学 | 56篇 |
眼科学 | 5篇 |
药学 | 53篇 |
肿瘤学 | 55篇 |
出版年
2023年 | 3篇 |
2021年 | 10篇 |
2020年 | 2篇 |
2019年 | 10篇 |
2018年 | 20篇 |
2017年 | 7篇 |
2016年 | 10篇 |
2015年 | 15篇 |
2014年 | 23篇 |
2013年 | 16篇 |
2012年 | 16篇 |
2011年 | 19篇 |
2010年 | 37篇 |
2009年 | 26篇 |
2008年 | 21篇 |
2007年 | 46篇 |
2006年 | 33篇 |
2005年 | 21篇 |
2004年 | 22篇 |
2003年 | 31篇 |
2002年 | 26篇 |
2001年 | 26篇 |
2000年 | 24篇 |
1999年 | 25篇 |
1998年 | 66篇 |
1997年 | 75篇 |
1996年 | 81篇 |
1995年 | 52篇 |
1994年 | 42篇 |
1993年 | 49篇 |
1992年 | 24篇 |
1991年 | 14篇 |
1990年 | 29篇 |
1989年 | 45篇 |
1988年 | 49篇 |
1987年 | 33篇 |
1986年 | 30篇 |
1985年 | 31篇 |
1984年 | 11篇 |
1983年 | 13篇 |
1982年 | 12篇 |
1981年 | 11篇 |
1980年 | 12篇 |
1979年 | 5篇 |
1978年 | 4篇 |
1977年 | 13篇 |
1976年 | 11篇 |
1975年 | 6篇 |
1969年 | 4篇 |
1966年 | 3篇 |
排序方式: 共有1222条查询结果,搜索用时 0 毫秒
1.
Isolated patellofemoral arthritis is an increasingly recognized entity, and is usually associated with previous patellofemoral dysplasia or instability. Patellofemoral arthroplasty (PFA) has evolved significantly in recent years, both in terms of implant design and importantly in the understanding of appropriate patient selection. This review outlines the indications and investigations for PFA, provides a brief history of the development of contemporary implants, and presents the clinical outcomes for the prostheses most commonly used in the UK. In addition, it provides a detailed surgical technique for implantation of an onlay implant, with tips on how to optimize patellofemoral biomechanics and thus achieve a consistently good outcome. 相似文献
2.
3.
Sonoelasticity imaging of prostate cancer: in vitro results 总被引:2,自引:0,他引:2
4.
5.
6.
7.
8.
Ten thrombocytopenic patients (platelets < 10–24 × 10(9)/L) who were refractory to platelet transfusion were investigated for their responsiveness to staphylococcal protein A column therapy. Nine patients had previously been treated with steroids, intravenous immune globulin, and/or other forms of immunosuppressive therapy without improvement in their transfusion response. All patients were receiving multiple platelet transfusions without achieving 1-hour corrected count increments (CCIs) > or = 7500. Eight patients had antibodies that reacted with platelets and were directed against HLA class I antigens, ABO antigens, and/or platelet-specific alloantigens. Plasma (500-2000 mL) from each patient was passed over a protein A silica gel column and then returned to the patient. Patients received from 1 to 14 treatments. A positive response to protein A therapy was defined as at least a doubling of the pretreatment platelet count and/or two successive 10- to 120-minute posttransfusion CCIs > or = 7500. Following plasma treatments, 6 of 10 patients responded with daily platelet counts that averaged 48 +/− 11 × 10(9) per L as compared with counts of 16 +/− 7 × 10(9) per L (p < 0.0005) before treatment. Posttransfusion CCI values determined in four of these patients averaged 2480 +/− 810 and 10,010 +/− 3540 (p < 0.005) before and after treatment, respectively. In contrast, among the four unresponsive patients, platelet counts averaged 10 +/− 9 and 13 +/− 10 × 10(9) per L (p = NS), respectively, while posttransfusion CCIs were 700 +/− 1410 and 1520 +/− 2460 (p = NS), respectively.(ABSTRACT TRUNCATED AT 250 WORDS) 相似文献
9.
D M Reboussin D C Goff E W Lipkin D M Herrington J Summerson M Steffes R J Crouse L Jovanovic M N Feinglos J L Probstfield M A Banerji D J Pettitt J Williamson 《Diabetic medicine》2004,21(10):1082-1089
OBJECTIVE: To examine the effect of short-term improvements in glycaemic control on brachial artery endothelial function as a marker of cardiovascular health. METHODS: Persons with Type 2 diabetes who were poorly controlled on oral therapy were randomly assigned to monotherapy with repaglinide or combination therapy with repaglinide plus metformin. Brachial artery flow-mediated vasodilation was assessed by ultrasonography at randomization and following 16 weeks of therapy. The primary outcome was change in brachial artery endothelial function from baseline. Comparison of randomized groups was a secondary aim. RESULTS: Eighty-six participants were randomized, and 83 were followed to study completion. Post occlusion brachial artery vasodilation was 3.74% at baseline and 3.82% following 16 weeks of therapy (P = 0.77). The treatment effect was 0.08% (95% CI: -0.48%, 0.64%). No difference was seen between treatment groups (P = 0.69). Overall, A1C was reduced from 8.3% to 7.0%, with a greater reduction in the combination therapy group (from 8.4% to 6.7%) than in the monotherapy group (from 8.3% to 7.3%, p for difference between groups = 0.01). Statistically significant reductions were observed in fasting glucose, and plasminogen activator inhibitor-1. Statistically significant increases were observed for fasting insulin, uric acid, weight and BMI. CONCLUSIONS: Brachial artery endothelial function was not influenced by short-term improvements in glycaemic control. The CONTROL DM group was successful in lowering A1C. Future research should explore more intensive and longer-lasting improvements in glycaemic control on endothelial function. Some data previously published in abstract form (Diabetes 2001; 50 (Suppl. 2): A217). 相似文献
10.
R A Price K Lunetta R Ness M A Charles M F Saad E Ravussin P H Bennett D J Pettitt W C Knowler 《International journal of obesity (2005)》1992,16(11):851-857
We examined distribution characteristics of the body mass index (BMI; weight/height; kg/m2) in a sample of 1128 male and 1372 female Pima Indians aged 15-65 years. We found that women had a higher mean and variance of BMI than men. From commingling analyses, we determined that the distribution of BMI could be accounted for either by a single skewed distribution or by a mixture of multiple normal components. These component distributions may be used to define provisional thresholds in selecting families for genetic studies. To ensure genetic segregation of obesity predisposing genes in Pima families will require that some members have BMIs > or = 40 kg/m2. 相似文献